(PC) Tran v. Kokor

CourtDistrict Court, E.D. California
DecidedJanuary 10, 2022
Docket1:18-cv-00010
StatusUnknown

This text of (PC) Tran v. Kokor ((PC) Tran v. Kokor) is published on Counsel Stack Legal Research, covering District Court, E.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
(PC) Tran v. Kokor, (E.D. Cal. 2022).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 EASTERN DISTRICT OF CALIFORNIA 10 11 KEVIN TRAN, Case No. 1:18-cv-00010 JLT (PC)

12 Plaintiff, ORDER WITHDRAWING FINDINGS AND RECOMMENDATIONS (Doc. 52); ORDER 13 v. GRANTING DEFENDANTS’ MOTION FOR SUMMARY JUDGMENT 14 WINFRED KOKOR, et al., (Doc. 35) 15 Defendants.

16 17 Before the Court is Defendants’ motion for summary judgment. (Doc. 35.) For the reasons 18 set forth below, the Court GRANTS the motion. 19 I. SUMMARY OF FACTS1 20 At the times relevant to this case, Mr. Tran was incarcerated at Substance Abuse 21 Treatment Facility and State Prison, Corcoran, and housed in Facility E. Pl.’s Resp. to Defs.’ 22 Statement of Undisputed Facts (“Pl.’s Resp.”) 1 (Doc. 44 at 1). Dr. Kokor and Nurse Powell were 23 employed at the Facility E medical clinic, and Dr. Kokor was Plaintiff’s primary care physician. 24 Id. 2. Plaintiff had a history of kidney stones, with one passing naturally in 2014. Id. 25 On October 31, 2016, Plaintiff began suffering severe abdominal pain; and on November 26 2, 2016, he began urinating blood. Id. 2-3. Plaintiff informed medical staff, and Dr. Kokor 27 1 Although Plaintiff disputes nearly all of Defendants’ proffered facts, except for some minor inconsistencies, the 1 diagnosed him with possible urolithiasis (kidney stones) and ordered a urine test. Defs.’ Resp. to 2 Pl.’s Statement of Disputed Facts (“Defs.’ Resp.”) 2-3 (Doc. 49 at 2-3). “Plaintiff was then 3 transferred to the Triage and Treatment Area (‘TTA’) for emergency treatment.” Id. 3. While at 4 TTA, Plaintiff was provided an injection of Toradol and Aleve for pain, plus one dose of 5 Ciprofloxacin (an antibiotic), then discharged. Id. 6 On November 3, 2016, Dr. Kokor examined Plaintiff and prescribed additional 7 Ciprofloxacin. Id. 3-4. According to Plaintiff, Dr. Kokor told Plaintiff that he believed a kidney 8 stone had passed, and thus a “urine strainer was unnecessary.” Id. 4. Dr. Kokor also “indicated 9 that there was to be a ‘follow up after [urine analysis] report for further review.’” Id. 10 On November 4, 2016, Plaintiff saw Nurse Powell for a follow-up appointment. Id. 11 Plaintiff informed her that his pain had decreased to a “4 out of 10” (from a previous “8 out of 12 10”), but that he was still experiencing more pain than normal. See id. 3, 5. Powell instructed 13 Plaintiff to continue taking Aleve on an as-needed basis and to seek further medical attention if 14 his pain or symptoms increased. Id. 5. Plaintiff’s pain subsided between November 4 and 15 December 18, 2016. Id. 6. 16 On December 18, 2016, Plaintiff again began suffering severe pain in his abdomen. Id. He 17 went to the Facility E medical clinic, and he was transferred to the TTA. Id. Dr. Scharffenberg 18 prescribed morphine for pain and ordered that Plaintiff be transferred to Mercy Hospital. Id. At 19 Mercy Hospital, a CT scan revealed that Plaintiff had an “obstructing . . . ureteral stone at the 20 ureterovesical juncture.” Id. 6-7. On December 20, 2016, Dr. Youngstrom, a urologist, performed 21 surgery, removed the kidney stone, and placed a “ureteral stent.” Id. 7. “Dr. Youngstrom 22 informed Plaintiff that the stone had become embedded in Plaintiff’s urinary tract.” Id. 23 In his notes, Dr. Youngstrom indicated that Plaintiff would need to follow up with him in 24 one week for “KUB and possible stent removal.” Id. Dr. Shah also advised Plaintiff that he would 25 need to follow up with Dr. Youngstrom in one to two weeks, and the “Physician Orders” and 26 “Physician Discharge Instructions” indicated the same. See id. Back at TTA, an unidentified 27 “nurse informed Plaintiff that he was going to have a follow-up appointment within 2 weeks with 1 On December 21, 2016, Dr. Kokor instructed Plaintiff to continue taking Flomax and anti- 2 inflammatory medications, and he ordered an X-ray and a follow-up to be scheduled with Dr. 3 Youngstrom within one to two weeks. Id. Plaintiff underwent the X-ray exam on December 23, 4 2016. Id. Dr. Kokor determined that the test results were “within normal limits” and that “no 5 other provided follow-up is required.” Id. 6 On January 4, 2017, Plaintiff submitted a request for medical attention because he was 7 experiencing pain in his flank region and because he had not yet seen Dr. Youngstrom for his 8 follow-up appointment. Id. 10. On January 6, 2017, Nurse Powell saw Plaintiff and instructed him 9 to continue taking Aleve for his pain. Id. 10. She and Dr. Kokor then submitted a request for a 10 follow-up appointment with Dr. Youngstrom, because the appointment had not been scheduled. 11 Id. 10-11. 12 On January 9, 2017, Plaintiff submitted another request for medical attention because he 13 was experiencing severe, sharp pain in his lower abdomen. Id. 11-12. Nurse Powell saw Plaintiff 14 and indicated that his follow-up appointment with Dr. Youngstrom would occur in a “very short 15 period.” Id. 12. After consulting with a doctor, Powell provided Plaintiff anti-inflammatory 16 medications and told him to continue taking Aleve. Id. 17 On January 10, 2017, Plaintiff went to the Facility E medical clinic because he was 18 experiencing “stabbing pains” in his abdomen and now urinating blood. Id. Dr. Chang prescribed 19 Bactrim and an injection of Toradol, and he ordered a follow-up with a doctor for the following 20 day. Id. 13. On January 11, 2017, Dr. Anderson ordered that Plaintiff be transferred to Mercy 21 Hospital. At Mercy Hospital, “Plaintiff was diagnosed with obstructive uropathy with possible 22 stent infection.” Id. 14. Dr. Youngstrom and Dr. Kakarla indicated that the follow-up appointment 23 with Dr. Youngstrom had not been scheduled. Id. “Dr. Youngstrom mentioned that he figured 24 Plaintiff’s follow-up with him was lost in the prison system.” Id. 15. Dr. Youngstrom determined 25 that, due to Plaintiff’s “minor symptoms and likely reactive leukocytosis,” the stent should be 26 removed. Id. 14-15. Dr. Youngstrom removed the stent “without complication” on January 12, 27 2017. Id. 15. 1 II. LEGAL STANDARD 2 Summary judgment is appropriate when the moving party “shows that there is no genuine 3 dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. 4 Civ. P. 56(a). The moving party “initially bears the burden of proving the absence of a genuine 5 issue of material fact.” In re Oracle Corp. Sec. Litig., 627 F.3d 376, 387 (9th Cir. 2010) (citing 6 Celotex Corp. v. Catrett, 477 U.S. 317, 323 (1986)). The moving party may accomplish this by 7 “citing to particular parts of materials in the record, including depositions, documents, 8 electronically stored information, affidavits or declarations, stipulations . . . , admissions, 9 interrogatory answers, or other materials,” or by showing that such materials “do not establish the 10 absence or presence of a genuine dispute, or that an adverse party cannot produce admissible 11 evidence to support the fact.” Fed. R. Civ. P. 56(c)(1)(A), (B). When the non-moving party bears 12 the burden of proof at trial, “the moving party need only prove that there is an absence of 13 evidence to support the non-moving party’s case.” Oracle Corp., 627 F.3d at 387 (citing Celotex, 14 477 U.S. at 325); see also Fed. R. Civ. P. 56(c)(1)(B). 15 Summary judgment should be entered against a party who fails to make a showing 16 sufficient to establish the existence of an element essential to that party’s case, and on which that 17 party will bear the burden of proof at trial. See Celotex, 477 U.S. at 322.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
In Re Oracle Corp. Securities Litigation
627 F.3d 376 (Ninth Circuit, 2010)
Walls v. Central Contra Costa Transit Authority
653 F.3d 963 (Ninth Circuit, 2011)
Toguchi v. Soon Hwang Chung
391 F.3d 1051 (Ninth Circuit, 2004)
Wilhelm v. Rotman
680 F.3d 1113 (Ninth Circuit, 2012)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Richards v. Nielsen Freight Lines
602 F. Supp. 1224 (E.D. California, 1985)
Cion Peralta v. T. Dillard
744 F.3d 1076 (Ninth Circuit, 2014)
John Colwell v. Robert Bannister
763 F.3d 1060 (Ninth Circuit, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
(PC) Tran v. Kokor, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pc-tran-v-kokor-caed-2022.